At CPAC we generate patient-derived organoids from a range of cancer types, including prostate and bladder cancers, to evaluate drug sensitivities and guide personalised selection of treatment as disease progresses. We perform real-time imaging, and conditioned media analyses, together with end-point metabolic, viability, and histopathological analyses to determine the effect of each compound on cancer organoids.
About this website
The Organoids Tank website was created on an independent initiative, publications reflect only the views of the project owner.
Centre de Recherche en Cancérologie de Marseille
27 bd Lei Roure
13273 Marseille cedex 09